Philippe Camus, M.D.

Dijon, France

Back to drug

The Drug-Induced Respiratory Disease Website

V.a

Myocarditis (can be fulminate/fulminant)

Typically acute. Can be fulminate/fulminant and fatal (PMID 30242316). General review at PMID 28540649. Recent addition to the lst of causal drugs include immune checkpoint inhibitors (PMID 28833116, 29801747)

Publications

Cesa K, Cunningham C, Harris T, Sunseri W

A Review of Extraintestinal Manifestations & Medication-Induced Myocarditis and Pericarditis in Pediatric Inflammatory Bowel Disease.

Cureus 2022 Jun;14;e26366 — 2022 Jun — e26366

Song HY, Seo GS

5-Aminosalicylic Acid-induced Myocarditis in a Patient with Atypical Ulcerative Colitis.

The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 2022 Jan 25;79;31-34 — 2022 Jan 25 — 31-34

Ali A, Kumaravel Kanagavelu AS, Rahimi A, Mehmood Z, Tariq AB, Das T, Elmdaah A

A Rare Case of Mesalazine-Induced Acute Myocarditis in a 19-Year-Old Female With Ulcerative Colitis.

Cureus 2021 Nov;13;e20036 — 2021 Nov — e20036

Taha ME, Abdalla A, Al-Khafaji J, Malik S

Mesalamine-Induced Myopericarditis: A Case Report and Literature Review.

Cardiology research 2019 Feb;10;59-62 — 2019 Feb — 59-62

Dias T, Santos A, Santos RM, Carvalho A

Recurrent mesalazine-induced myopericarditis in a patient with ulcerative colitis.

BMJ case reports 2019 Feb 01;12; — 2019 Feb 01

Tagawa M, Nakamura Y, Okura Y, Nanba H, Kishi K, Akashi E, Ochiai Y, Asai Y, Chinushi M

Successful Treatment of Acute Fulminant Eosinophilic Myocarditis in a Patient with Ulcerative Colitis Using Steroid Therapy and Percutaneous Cardiopulmonary Support.

Internal medicine (Tokyo, Japan) 2019 Apr 15;58;1111-1118 — 2019 Apr 15 — 1111-1118

Doganay L, Akinci B, Pekel N, Simsek I, Akpinar H

Mesalazine-induced myopericarditis in a patient with ulcerative colitis.

International journal of colorectal disease 2006 Mar;21;199-200 — 2006 Mar — 199-200

Marteau P, Nelet F, Le Lu M, Devaux C

Adverse events in patients treated with 5-aminosalicyclic acid: 1993-1994 pharmacovigilance report for Pentasa in France.

Alimentary pharmacology & therapeutics 1996 Dec;10;949-56 — 1996 Dec — 949-56

Camus P, Piard F, Ashcroft T, Gal AA, Colby TV

The lung in inflammatory bowel disease.

Medicine 1993 May;72;151-83 — 1993 May — 151-83